Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention - Scorecard - MDSpire
Advertisement
Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
Clinical Scorecard: Relationship Between Hemoglobin Glycation Index and Overall Mortality in NSTEMI Patients Undergoing Percutaneous Coronary Intervention
At a Glance
Category
Detail
Condition
Key Mechanisms
HGI as a marker for cardiovascular risk stratification.
Target Population
Care Setting
Key Highlights
Higher HGI associated with lower risk of all-cause mortality (HR=0.57, 95% CI: 0.40–0.82, P=0.002).
Patients in highest HGI tertile had significantly lower mortality risk (HR=0.26, 95% CI: 0.10–0.66, P=0.004).
Guideline-Based Recommendations
Diagnosis
Assess HGI as a complementary marker for risk stratification in NSTEMI.
Management
Maintain glycated hemoglobin (HbA1c) below 7% in coronary artery disease.
Monitoring & Follow-up
Monitor HGI alongside HbA1c for comprehensive glycemic assessment.
Risks
Consider potential increased mortality risk with intensive glucose-lowering strategies.
Patient & Prescribing Data
635 patients with NSTEMI who underwent PCI.
HGI may provide additional prognostic information beyond traditional glycemic markers.
Clinical Best Practices
Incorporate HGI in cardiovascular risk assessment for NSTEMI patients.
Utilize subgroup analysis to tailor management strategies based on sex differences.
